CIK 0001534120 · Non-accelerated filer<br>Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450705648
- Phone
- 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,865,893
- in 5 filings, $1.9M under 10b5-1 plans
Net −$1,865,893. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-28 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +163,000 | 163,000 | ||
| 2025-01-28 | NEIL GARRY ARTHUR CEO and Chairman of the Board | Grant or award · Stock Option (Right to Buy) | +411,000 | 411,000 | ||
| 2025-01-28 | Doyle Mittie Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2025-01-01 | Riley Jennifer Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2024-11-13 | Almenoff June Sherie Director | Purchase | +500 | $13.00 | $7K | 1,000 |
| 2024-11-12 | Almenoff June Sherie Director | Purchase | +500 | $12.50 | $6K | 500 |
| 2024-08-13 | Goldman Jonathan Director | Grant or award · Stock Option (Right to Buy) | +24,600 | 24,600 | ||
| 2024-08-13 | Goldman Jonathan Director | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2024-08-13 | Chan Mitchell Director | Grant or award · Stock Option (Right to Buy) | +24,600 | 24,600 | ||
| 2024-08-13 | Chan Mitchell Director | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2024-08-13 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +24,600 | 24,600 | ||
| 2024-08-13 | Almenoff June Sherie Director | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2024-08-13 | KANTOFF AARON Director | Grant or award · Stock Option (Right to Buy) | +24,600 | 24,600 | ||
| 2024-08-13 | KANTOFF AARON Director | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2024-08-13 | Truex Samantha Director | Grant or award · Stock Option (Right to Buy) | +24,600 | 24,600 | ||
| 2024-08-13 | Truex Samantha Director | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2024-08-13 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +24,600 | 24,600 | ||
| 2024-08-13 | KAPLAN GILLA Director | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2024-08-13 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +186,700 | 186,700 | ||
| 2024-08-13 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award · Restricted Stock Units | +72,600 | 72,600 |
Page 10 of 11 · 202 trades